Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-032990

Chief Financial Officer sold 3,524 shares at $72.69 ($256,160)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Prasad Raju Chief Financial Officer 2024-03-14 Option exercise +10,000 10,000 D
Prasad Raju Chief Financial Officer 2024-03-15 Sale −3,524 $72.69 $256,160 6,476 D
Derivatives
Prasad Raju Chief Financial Officer 2024-03-14 Option exercise · Restricted Stock Units −10,000 30,000 D
Open-market sales · 3,524 sh · avg $72.69 · $256,160
Loading xslF345X05/ownership.xml…